194 related articles for article (PubMed ID: 14984959)
1. An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: implications for informed decision making.
Brain K; Gravell C; France E; Fiander A; Gray J
Gynecol Oncol; 2004 Mar; 92(3):905-13. PubMed ID: 14984959
[TBL] [Abstract][Full Text] [Related]
2. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
[TBL] [Abstract][Full Text] [Related]
3. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.
Meiser B; Butow P; Barratt A; Friedlander M; Gattas M; Kirk J; Suthers G; Walpole I; Tucker K
Gynecol Oncol; 1999 Oct; 75(1):122-9. PubMed ID: 10502438
[TBL] [Abstract][Full Text] [Related]
4. Women awaiting hysterectomy: a qualitative study of issues involved in decisions about oophorectomy.
Bhavnani V; Clarke A
BJOG; 2003 Feb; 110(2):168-74. PubMed ID: 12618161
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction.
Swisher EM; Babb S; Whelan A; Mutch DG; Rader JS
J Reprod Med; 2001 Feb; 46(2):87-94. PubMed ID: 11255821
[TBL] [Abstract][Full Text] [Related]
6. A qualitative study of women's experiences of familial ovarian cancer screening.
Lifford KJ; Clements A; Fraser L; Lancastle D; Brain K;
Psychooncology; 2013 Nov; 22(11):2576-84. PubMed ID: 23801640
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer.
Tiller K; Meiser B; Gaff C; Kirk J; Dudding T; Phillips KA; Friedlander M; Tucker K
Med Decis Making; 2006; 26(4):360-72. PubMed ID: 16855125
[TBL] [Abstract][Full Text] [Related]
8. Women's decisions regarding management of breast cancer risk.
MacDonald DJ
Medsurg Nurs; 2002 Aug; 11(4):183-6. PubMed ID: 12219430
[TBL] [Abstract][Full Text] [Related]
9. Deciding about prophylactic oophorectomy: what is important to women at increased risk of ovarian cancer?
Fry A; Rush R; Busby-Earle C; Cull A
Prev Med; 2001 Dec; 33(6):578-85. PubMed ID: 11716653
[TBL] [Abstract][Full Text] [Related]
10. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.
Hallowell N; Foster C; Eeles R; Ardern-Jones A; Watson M
Soc Sci Med; 2004 Aug; 59(3):553-65. PubMed ID: 15144764
[TBL] [Abstract][Full Text] [Related]
11. Decision making about prophylactic oophorectomy among at-risk women: psychological influences and implications.
Miller SM; Fang CY; Manne SL; Engstrom PF; Daly MB
Gynecol Oncol; 1999 Dec; 75(3):406-12. PubMed ID: 10600298
[TBL] [Abstract][Full Text] [Related]
12. [Prophylactic mastectomy in women at high risk for breast and ovarian cancer: qualitative analysis of the decision making process and long-term satisfaction of two women carrying a BRCA1-mutation].
Vodermaier A; Bauerfeind I; Untch M; Nestle-Krämling C
Psychother Psychosom Med Psychol; 2006; 56(9-10):351-61. PubMed ID: 16804803
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic oophorectomy in women at increased cancer risk.
Domchek SM; Rebbeck TR
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):27-30. PubMed ID: 17218848
[TBL] [Abstract][Full Text] [Related]
14. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
15. The role of prophylactic oophorectomy in cancer prevention.
Averette HE; Nguyen HN
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S38-41. PubMed ID: 7835808
[TBL] [Abstract][Full Text] [Related]
16. Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers.
Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Lubsen-Brandsma L; Massuger LF; Mourits MJ; Gaarenstroom KN; van Dorst EB; van der Putten H; Boonstra H; Aaronson NK
J Clin Oncol; 2007 Jan; 25(3):301-7. PubMed ID: 17235045
[TBL] [Abstract][Full Text] [Related]
17. Psychological adjustment among male partners in response to women's breast/ovarian cancer risk: a theoretical review of the literature.
Sherman KA; Kasparian NA; Mireskandari S
Psychooncology; 2010 Jan; 19(1):1-11. PubMed ID: 19472298
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.
Brunsvold AN; Wung SF; Merkle CJ
J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160
[TBL] [Abstract][Full Text] [Related]
19. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Madalinska JB; Hollenstein J; Bleiker E; van Beurden M; Valdimarsdottir HB; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
J Clin Oncol; 2005 Oct; 23(28):6890-8. PubMed ID: 16129845
[TBL] [Abstract][Full Text] [Related]
20. 'You don't want to lose your ovaries because you think 'I might become a man". Women's perceptions of prophylactic surgery as a cancer risk management option.
Hallowell N
Psychooncology; 1998; 7(3):263-75. PubMed ID: 9638787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
